화학공학소재연구정보센터
Polymer(Korea), Vol.36, No.1, 1-8, January, 2012
초임계 유체를 이용한 PLGA 입자 제조에 첨가제가 미치는 영향
Effect of an Excipient on the Formation of PLGA Particles Using Supercritical Fluid
E-mail:
초록
본 연구에서는 초임계 aerosol solvent extraction system(ASES) 공정을 이용하여 poly(lactic-co-glycolic acid)(PLGA) 미립자를 제조하기 위해 첨가제로 hydroxypropyl-β-cyclodextrin (HP-β-CD)를 사용하였으며, HP-β-CD의 첨가량이 PLGA 입자의 형상에 미치는 영향을 조사하였다. 또한 항암제인 파클리탁셀이 봉입된 미립자를 제조하여 HP-β-CD의 함량에 따른 약물 방출 특성의 변화를 고찰하였다. PLGA(75:25)의 경우 HP-β-CD를 고분자 중량대비 약 40%까지, PLGA(50:50)의 경우 약 30%까지 첨가하였을 때 미립자가 형성되었으며, HP-β-CD의 첨가량이 이보다 더 적은 경우에는 PLGA가 필름 형태로 형성되었다. 파클리탁셀이 봉입된 PLGA/HP-β-CD 미립자의 경우 HP-β-CD의 함량이 증가함에 따라 더 빠른 속도로 약물이 방출됨을 확인할 수 있었다.
In this study, we employed hydroxypropyl-β-cyclodextrin (HP-β-CD) as an excipient to produce poly(lactic-co-glycolic acid) (PLGA) fine particles by a supercritical fluid process, called aerosol solvent extraction system (ASES), and investigated the effect of HP-β-CD content on the morphology of the particles. The influence of HP-β-CD on the drug release characteristics of paclitaxel-loaded PLGA particles was also evaluated. Fine particles were obtained when the HP-β-CD content in PLGA/HP-β-CD mixtures was greater than 40% and 30%, respectively, for PLGA(75:25) and PLGA(50:50), whereas a film-like precipitate was obtained for lower HP-β-CD content. The release rate for paclitaxel loaded PLGA(75:25)/HP-β-CD particles was found to increase with HP-β-CD content.
  1. Kwon GS, Polymeric Drug Delivery Systems, Taylor & Francis Group, Boca Raton (2005)
  2. Kumar MN, Kumar N, Drug Dev. Ind. Pharm., 27, 1 (2001)
  3. Park JH, Ye M, Park K, Molecules., 10, 146 (2005)
  4. Anderson JM, Shive MS, Adv. Drug Del. Rev., 28, 5 (1997)
  5. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM, Chem. Rev., 99(11), 3181 (1999)
  6. Lu Y, Chen SC, Adv. Drug Del. Rev., 56, 1621 (2004)
  7. Li S, J. Biomed. Mat. Res., 48, 342 (1998)
  8. Lee DI, Ling Y, Sung MH, Park IH, Polym.(Korea), 31(2), 168 (2007)
  9. Mishima K, Adv. Drug Del. Rev., 60, 411 (2008)
  10. Breitenbach A, Mohr D, Kissel T, J. Control. Release., 63, 53 (2000)
  11. Miguel F, Martin A, Mattea F, Cocero MJ, Chem. Eng. Process., 47(9-10), 1594 (2008)
  12. Lee LY, Wang CH, Smith KA, J. Control. Release., 125, 96 (2008)
  13. Connon CS, Falk RF, Randolph TW, Macromolecules, 32(6), 1890 (1999)
  14. Liu DH, Tomasko DL, J. Supercrit. Fluids, 39(3), 416 (2007)
  15. Thote AJ, Gupta RB, Biol. Med., 1, 85 (2005)
  16. Kang YQ, Yin GF, Ping OY, Huang ZB, Yao YD, Liao XM, Chen AZ, Pu XM, J. Colloid Interface Sci., 322(1), 87 (2008)
  17. Challa R, Ahuja A, Ali J, Khar RK, AAPS Pharm.Sci. Tech., 6, E329 (2005)
  18. Liu L, Guo QX, J. Incl. Phenom. Macrocycl. Chem., 42, 1 (2002)
  19. Shin KM, Dong T, He Y, Inoue Y, J. Polym. Sci. B: Polym. Phys., 43(12), 1433 (2005)
  20. Ceccato M, Lonostro P, Baglioni P, Langmuir, 13(9), 2436 (1997)
  21. Xie DM, Yang KS, Sun WX, Curr. Appl. Phys., 7S1, e15 (2007)
  22. Li X, Li J, J. Biomed. Mater. Res. Part A., 86A, 1055 (2007)
  23. Li J, Li X, Ni X, Wang X, Li H, Zhou Z, Key Eng.Mater., 288, 117 (2005)
  24. Constantin M, Fundueanu G, Bortolotti F, Cortesi R, Ascenzic P, Menegatti E, Int. J. Pharm., 285, 87 (2004)
  25. Rajasingam R, Lioe L, Pham QT, Lucien FP, J. Supercrit. Fluids, 31(3), 227 (2004)
  26. De Marco I, Reverchon E, Powder Technol., 183(2), 239 (2008)
  27. Davies OR, Lewis AL, Whitaker MJ, Tai H, Shakesheff KM, Howdle SM, Adv. Drug Del. Rev., 60, 373 (2008)
  28. Turk M, Upper G, Steurenthaler M, Hussein K, Wahl MA, J. Supercrit. Fluids, 39(3), 435 (2007)
  29. Dordunoo SK, Burt HM, Inter. J. Pharm., 133, 191 (1996)
  30. Cserhati T, Forgacs E, Hollo J, J. Pharm. Biomed.Anal., 13, 533 (1995)